Pandemic news has been so dominated in the past week by reports of skyrocketing COVID-19 numbers and prospective vaccines that another important breakthrough on the coronavirus front has been somewhat overlooked.
Last week the U.S. Food and Drug Administration issued an emergency use authorization for the first COVID-19 diagnostic test for self-testing at home that provides rapid results.
Subscribe to keep reading
This story is from our archive. Get your SandPaper Annual Pass for access to our digital archive, plus everything else a pass includes. Details below.
Annual Pass — $18 Details
365-day access to:
- The complete SandPaper digital archive (stories date back to 2012).
- Full photo galleries from our photographers.
- The entire catalog of SandPaper games, puzzles and quizzes.
How it works
- Enter your email below and click to pay the one-time $18. Card details are entered on Stripe’s secure page.
- You’re in straight away — no password to create, and nothing to set up or manage.
- You stay signed in. If you’re ever signed out, or you read on a new phone or computer, we’ll email you a code to get you back in.
- Never auto-renews. Your pass is good for one year. We will email you when it expires so you can renew if you’d like.
See our site policies for more information.
or sign in
Already a subscriber? We’ll email a code to get you back in.
